Skip to content

Enhancing Medical Researchers' Self-learning With an Intelligent Language Model

A Superiority Randomized Controlled Trial of the Effect of a Novel Intelligent Language Model on the Self-learning Ability of Medical Researchers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06015178
Enrollment
60
Registered
2023-08-29
Start date
2023-08-30
Completion date
2024-04-30
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interdisciplinary Research, Medical Artificial Intelligence, Self-Directed Learning

Keywords

medical artificial intelligence, Large Language Model, superiority randomized controlled trial, Self-Directed Learning

Brief summary

Solving medical scientific problems is a crucial driving force behind the advancement of medical disciplines. As the complexity of scientific questions increases, an increasing number of problems require interdisciplinary collaboration to be resolved. However, most medical researchers lack interdisciplinary background knowledge and require substantial time to systematically learn relevant knowledge and skills. Furthermore, the continuous emergence of new knowledge and skills emphasizes the importance of researchers' ability for autonomous learning in the medical field. Therefore, to promote the development of medical disciplines, there is an urgent need for an effective method to enhance researchers' self-directed learning abilities for conducting interdisciplinary research. The next-generation artificial intelligence language models, exemplified by ChatGPT, hold great potential in assisting researchers to access knowledge and information from various domains. Whether researchers can leverage such AI tools to enhance their self-directed learning abilities for conducting interdisciplinary research remains to be further explored. Additionally, concerns have been raised regarding the potential degradation of cognitive abilities through their use, although valid evidence is currently lacking. To investigate whether AI tools, represented by ChatGPT, can effectively assist medical researchers in conducting interdisciplinary research and whether their usage may negatively impact researchers' cognitive abilities, a randomized controlled trial is warranted. This trial aims to ascertain the potential benefits and risks associated with utilizing AI tools in the medical research domain.

Interventions

OTHERIntelligent Language Model

Subjects must use the intelligent language model to complete the retrieval and protocol design execution of an interdisciplinary task, in addition to Google search, literature search and book query.

OTHERcontrol

Subjects can only use Google search, literature retrieval and book query, and cannot use any AI-driven conversational natural language processing tools to complete the retrieval and protocol design execution of an interdisciplinary task.

Sponsors

Zhongshan Ophthalmic Center, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 28 Years
Healthy volunteers
Yes

Inclusion criteria

* Junior ophthalmologist with 1-3 years of clinical experience * 20-28 years old, regardless of gender * No prior experience in interdisciplinary research involving digital medicine * Self-reported a minimum of 20 hours of participation in this study during the trial period * Agree to participate in this study and sign informed consent

Exclusion criteria

* Individuals with reading difficulties or reading disabilities * Reluctance to participate in this study

Design outcomes

Primary

MeasureTime frameDescription
completion ratethrough study completion, an average of 9 monthsThe number of people who completed the task within the given time / the total number of people in the group

Secondary

MeasureTime frameDescription
Feasibility of the research programthrough study completion, an average of 9 monthsThe feasibility of the scheme is scored by a scoring group composed of experts. The feasibility is divided into 1-5 points according to the correctness and integrity of the key steps and details of the test. The higher the score, the higher the feasibility. The 1 point represents more than half of the key steps are missing or wrong, and the 5 point represents all the key steps and the details are appropriate.

Countries

China

Contacts

Primary Contactwenben chen, Doctor
weberchan@foxmail.com+8618819472798
Backup Contactyuanjun shang, Doctor
shangyj@mail2.sysu.edu.cn+8613003970091

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026